Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 4

OKYO Pharma Limited

OKYONASDAQEQUITYCurrent

SEC Filing

Filed Jul 23, 2026Accepted Jul 23, 2026, 4:15 PM EDTCIK 1849296Accession 0001493152-26-034408
Share

Company context

Current securities

Recent company filings

  1. 6-K filingSep 9, 2026
  2. 6-K filingSep 8, 2026
  3. 20-F/A filingAug 7, 2026
  4. 4/A filingAug 7, 2026
  5. 4/A filingAug 7, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗